Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Retinoic acid is effective for treating eruptive vellus hair cysts.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Tattoo machine-assisted drug delivery may improve hair growth in androgenetic alopecia.

An elderly Chinese man lost all his hair after taking a new heart medication.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.